CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences (Nasdaq:HLCS), a life science company focused on innovative genetic analysis technologies, announced today that Elisabeth Allison, PhD, has been named to the Helicos Board of Directors. Dr. Allison is a partner at ANZI Partners, a business consulting firm specializing in development and negotiation of joint ventures, strategic alliances and broad based licensing agreements.
